Search Results
Results for: VERNALIS PLC (Save this search)
Number of Results: 6
Ligand Closes GBP 32.8m Acquisition of UK Structure-Based Drug Discovery Specialist Vernalis
11 October 2018 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has closed the acquisition of the entire issued and to be issued shares of UK-based Vernalis pl...

LIGAND CLOSES GBP 32.8M ACQUISITION OF UK STRUCTURE-BASED DRUG DISCOVERY SPECIALIST VERNALIS
US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has closed the acquisition of the entire issued and to be issued shares of UK-based Vernalis plc (LSE: VER) throu...

Ligand Makes Offer to Acquire UK Structure-Based Drug Discovery Specialist Vernalis for GBP 32.8m
10 August 2018 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has declared its firm intention to acquire the entire issued and to be issued shares of UK-based...

Vernalis Acquires US Rights to Pragma´s Amoxicillin Formulation
6 October 2015 - UK-based drugmaker Vernalis plc (LSE: VER) has acquired US rights to Moxatag (amoxicillin extended-release tablets) from Pragma Pharmaceuticals, LLC (Pragma), the ...

VERNALIS ACQUIRES US RIGHTS TO PRAGMA´S AMOXICILLIN FORMULATION
UK-based drugmaker Vernalis plc (LSE: VER) has acquired US rights to Moxatag (amoxicillin extended-release tablets) from Pragma Pharmaceuticals, LLC (Pragma), the company's US...

CEO says Vernalis moving towards acquisition
Ian Garland, at the helm of UK pharmaceutical researcher Vernalis (LON:VER), said on 8 July 2009 he was nearing an acquisition deal promised in November 2008 when he took up the CE...










You can compare news articles by clicking on the tick buttons